InvestWiser

Hofseth Biocare ASA

HBCOslo BørsConsumer defensiveMarket value 532 m NOK
1.05NOK +4.0%
last day · Price as of 19 November 2026

The answer first

Does Hofseth Biocare beat the market?

No, Hofseth Biocare has not beaten the market over the last year.

Hofseth Biocare−38.2%Oslo Børs (OSEBX)+30.6%
  • The ranking · Quality, value and trend combined

    Better than 2% of Nordic stocks

    • Quality15
    • Value8
    • Trend19

    No. 76 of 78 in consumer defensive

Max for seven days

Follow Hofseth Biocare with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Hofseth Biocare

From today, at a price of 1.05 NOK. Write why you follow Hofseth Biocare, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Hofseth Biocare

Your first answer is free, no account needed.

Do you own Hofseth Biocare, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Hofseth Biocare and a few more. Free, no card.

Past year against the exchange and Super Stock
Hofseth Biocare−38.2%Oslo Børs (OSEBX)+30.6%Super Stock+46.4%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Hofseth Biocare has fallen 38.2% over the past year, including dividends.
  • Overall, Hofseth Biocare ranks better than 2% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 83.2%. The price is 90.4% below its peak now.

Who owns Hofseth Biocare? See the major shareholders and their stakes

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

2

Quality, value and trend together. Better than 2% of Nordic stocks.

No. 76 of 78 in consumer defensive

Quality15
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 65 of 79 in consumer defensiveTypical in consumer defensive: 42Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity−59.29
  • Asset turnoverSales divided by everything the company owns0.75
  • Return on equityProfit divided by equity−444.6%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value8
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 75 of 78 in consumer defensiveTypical in consumer defensive: 55Typical in the Nordics: 50

  • P/BPrice divided by equitynegative earnings
  • P/SPrice divided by sales1.9
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend19
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 63 of 79 in consumer defensiveTypical in consumer defensive: 48Typical in the Nordics: 50

  • 3 months−19.8%
  • 6 months−18.6%
  • 9 months−19.8%
  • 12 months−38.2%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−21.1%
3 years, per year
−27.0%
5 years, per year
−32.6%
10 years, per year
−3.2%
Largest fall, 3 years
−83.2%
From a peak to the bottom
From the peak now
−90.4%
How far the price is from the peak
Volatility, 1 year
66.1%
How much the price swings over a year
Beta, 1 year
−0.07
How much the price moves when the market moves

Return with dividends reinvested.

About Hofseth Biocare

Hofseth Biocare ASA is a company in consumer defensive, listed on Oslo Børs. By market value, Hofseth Biocare is number 21 of 25 companies in consumer defensive on Oslo Børs. Hofseth Biocare has not paid a dividend in the past twelve months. Of the three measures in the ranking, Hofseth Biocare is strongest on trend, better than 19% of Nordic stocks. The share trades in NOK. It has around 78 employees.

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

See the full analysis of Hofseth Biocare.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other consumer defensive stocks on Oslo Børs

Explore the stock market